Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 149

1.

Mantle-cell lymphoma: classification and therapeutic implications.

Fisher RI.

Ann Oncol. 1996;7 Suppl 6:S35-9. Review.

PMID:
9010577
[PubMed - indexed for MEDLINE]
2.

Mantle cell lymphoma: correlation of clinical outcome and biologic features with three histologic variants.

Majlis A, Pugh WC, Rodriguez MA, Benedict WF, Cabanillas F.

J Clin Oncol. 1997 Apr;15(4):1664-71.

PMID:
9193367
[PubMed - indexed for MEDLINE]
3.
4.

Management of mantle cell lymphoma.

Armitage JO.

Oncology (Williston Park). 1998 Oct;12(10 Suppl 8):49-55. Review.

PMID:
9830633
[PubMed - indexed for MEDLINE]
5.

[R.E.A.L. classification of non-Hodgkin lymphoma from the clinico-oncologic viewpoint].

Meusers P, Brittinger G.

Praxis (Bern 1994). 1998 Jun 3;87(23):793-800. German.

PMID:
9654985
[PubMed - indexed for MEDLINE]
6.

Long term outcome of ocular adnexal lymphoma subtyped according to the REAL classification. Revised European and American Lymphoma.

Auw-Haedrich C, Coupland SE, Kapp A, Schmitt-Gräff A, Buchen R, Witschel H.

Br J Ophthalmol. 2001 Jan;85(1):63-9.

PMID:
11133714
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

[Mantle cell lymphoma: clinicopathologic features and prognostic factors of 102 cases occurring in Chinese patients].

Ji H, Li GD, Li FY, Bai YQ, Chen Y, Yang MZ, Wang LJ, Tang Y, Zhang P, Xia T, Li C, Feng J, Zou ZK, Yixi JC.

Zhonghua Bing Li Xue Za Zhi. 2007 Nov;36(11):730-5. Chinese.

PMID:
18307875
[PubMed - indexed for MEDLINE]
8.

Diffuse aggressive lymphoma.

Fisher RI, Miller TP, O'Connor OA.

Hematology Am Soc Hematol Educ Program. 2004:221-36. Review.

PMID:
15561685
[PubMed - indexed for MEDLINE]
Free Article
9.

[Recent progress in the management of malignant lymphoma].

Ohnishi K.

Gan To Kagaku Ryoho. 1997 Jul;24(9):1074-8. Review. Japanese.

PMID:
9239159
[PubMed - indexed for MEDLINE]
10.

REAL classification of malignant lymphomas in the Republic of Korea: incidence of recently recognized entities and changes in clinicopathologic features. Hematolymphoreticular Study Group of the Korean Society of Pathologists. Revised European-American lymphoma.

Ko YH, Kim CW, Park CS, Jang HK, Lee SS, Kim SH, Ree HJ, Lee JD, Kim SW, Huh JR.

Cancer. 1998 Aug 15;83(4):806-12. Erratum in: Cancer 1999 Jan 1;85(1):256.

PMID:
9708949
[PubMed - indexed for MEDLINE]
11.

Treatment of aggressive non-Hodgkin's lymphoma.

Coiffier B.

Semin Oncol. 1999 Oct;26(5 Suppl 14):12-20. Review.

PMID:
10561013
[PubMed - indexed for MEDLINE]
14.

Treatment of mantle cell lymphoma: targeting the microenvironment.

Drach J, Seidl S, Kaufmann H.

Expert Rev Anticancer Ther. 2005 Jun;5(3):477-85. Review.

PMID:
16001955
[PubMed - indexed for MEDLINE]
15.

Mantle cell lymphomas.

Rodriguez MA, Pugh WC.

Cancer Treat Res. 1996;85:41-50. Review.

PMID:
9043774
[PubMed - indexed for MEDLINE]
16.

Non-Hodgkin's lymphoma: the evolving role of purine analogues.

Zinzani PL.

Best Pract Res Clin Haematol. 2002 Sep;15(3):505-16. Review.

PMID:
12468402
[PubMed - indexed for MEDLINE]
17.
18.

Blastoid variants of mantle cell lymphoma: frequent bcl-1 rearrangements at the major translocation cluster region and tetraploid chromosome clones.

Ott G, Kalla J, Ott MM, Schryen B, Katzenberger T, Müller JG, Müller-Hermelink HK.

Blood. 1997 Feb 15;89(4):1421-9.

PMID:
9028966
[PubMed - indexed for MEDLINE]
Free Article
19.

[Increased response rate with rituximab in relapsed and refractory follicular and mantle cell lymphomas -- results of a prospective randomized study of the German Low-Grade Lymphoma Study Group].

Forstpointner R, Hänel A, Repp R, Hermann S, Metzner B, Pott C, Hartmann F, Rothmann F, Böck HP, Wandt H, Unterhalt M, Hiddemann W.

Dtsch Med Wochenschr. 2002 Oct 25;127(43):2253-8. German.

PMID:
12397539
[PubMed - indexed for MEDLINE]
20.

Rituximab for aggressive non-Hodgkin's lymphomas relapsing after or refractory to autologous stem cell transplantation.

Pan D, Moskowitz CH, Zelenetz AD, Straus D, Kewalaramani T, Noy A, Qin J, Teruya-Feldstein J, Portlock CS.

Cancer J. 2002 Sep-Oct;8(5):371-6.

PMID:
12416894
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk